As of 2025-09-15, the Relative Valuation of KemPharm Inc (KMPH) is (22.57) USD. This relative valuation is based on P/E multiples. With the latest stock price at 5.81 USD, the upside of KemPharm Inc based on Relative Valuation is -488.5%.
The range of the Relative Valuation is (21.82) - (22.76) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 16.2x - 18.9x | 18.8x |
| Forward P/E multiples | 18.1x - 19.7x | 18.8x |
| Fair Price | (21.82) - (22.76) | (22.57) |
| Upside | -475.5% - -491.7% | -488.5% |
| Date | P/E |